Ads
related to: survival food companies4patriots.com has been visited by 10K+ users in the past month
Search results
FDA delays decision on Dupixent in COPD; Summit makes a bold claim
BioPharma Dive via Yahoo Finance· 11 hours agoRegeneron and Sanofi now expect an FDA verdict in September. Elsewhere, Summit claimed victory over...
FDA sets review date for Merck's KEYTRUDA in mesothelioma treatment By Investing.com
Investing.com· 2 days agoMerck & Co., Inc., a global healthcare leader, has announced that the U.S. Food and Drug...
How Korean heritage and traditions shaped these two Asian-American brands
The Independent via Yahoo News· 6 hours ago‘I aimed to create a space where we could tell our stories in a big bold way without compromising...
As temperatures in India break records, ancient terracotta air coolers are helping fight extreme...
BBC News· 7 hours agoIn India's scorching summer heat, the ancient practice of chilling water in terracotta pots is...
ASCO 2024: Rakuten’s photoimmunotherapy and Keytruda combo shows efficacy in HNSCC
Clinical Trials Arena via Yahoo Finance· 3 days agoFollowing the positive results, the company now plans to start a global Phase III clinical trial...
Gilead's Trodelvy fails to meet main goal in late-stage cancer study
Reuters· 1 day agoShares of Gilead fell 3.3% in extended trade after the company said the drug did not meet the main...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 1 day agoPhase 3 CARES-310 study found combination of camrelizumab and rivoceranib continued to show sustained long-term survival compared with sorafenib as a first-line treatment ...
BMS secures another EC approval for Opdivo combination
Pharmaceutical Technology via Yahoo Finance· 2 days agoPreviously, there were no marketed therapies that improved overall survival in patients with...
Brussels, my love? The future of the Green Deal after the elections
Euronews via Yahoo News· 7 days agoIn this edition of our weekly talk show, host Stefan Grobe and his guests talk about the future of...
Transcenta’s Osemitamab succeeds in Phase IIa G/GEJ cancer triple combo trial
Clinical Trials Arena via Yahoo Finance· 3 days agoOsemitamab is a high-affinity...first-line metastatic setting, with immunotherapies expected to...
Ads
related to: survival food companies4patriots.com has been visited by 10K+ users in the past month